Literature DB >> 3717905

Epidemiology of clinically diagnosed Alzheimer's disease.

W A Rocca, L A Amaducci, B S Schoenberg.   

Abstract

This report reviews the current status of descriptive and analytic epidemiology of clinically diagnosed Alzheimer's disease (AD). Since AD can be diagnosed with certainty only at autopsy, currently available epidemiological data are based on a presumed clinical diagnosis. Current data indicate that AD represents a major health problem, at least in the developed countries. The prevalence ratio for AD ranges between 1.9 and 5.8 cases per 100 population aged 65 and over. Moreover, its prevalence is likely to increase in the next twenty years as a consequence of current demographic trends. The prevalence ratio for AD increases steeply with age and is higher in females. Incidence rates show a similar pattern, suggesting that AD should not be subdivided in a presenile and a senile form based on age of onset alone. Annual incidence rates of 2.4 cases per 100,000 population between ages 40 and 60, and 127 cases per 100,000 population after age 60 have been reported. Several case-control studies show that the occurrence of either dementia or Down's syndrome in other family members, advanced age of the mother at subject's birth, and head injury are possible risk factors.

Entities:  

Mesh:

Year:  1986        PMID: 3717905     DOI: 10.1002/ana.410190502

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  42 in total

Review 1.  Cognitive screening tests: an aid in the care of elderly outpatients.

Authors:  H White; P B Davis
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

2.  Fast decay of iconic memory in observers with mild cognitive impairments.

Authors:  Zhong-Lin Lu; James Neuse; Stephen Madigan; Barbara Anne Dosher
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

3.  Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Authors:  Emily R Rosario; Lilly Chang; Elizabeth H Head; Frank Z Stanczyk; Christian J Pike
Journal:  Neurobiol Aging       Date:  2009-05-09       Impact factor: 4.673

Review 4.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

5.  Brain testosterone deficiency leads to down-regulation of mitochondrial gene expression in rat hippocampus accompanied by a decline in peroxisome proliferator-activated receptor-γ coactivator 1α expression.

Authors:  Takeshi Hioki; Shunya Suzuki; Megumi Morimoto; Tsuneo Masaki; Ryuichi Tozawa; Shigeru Morita; Takashi Horiguchi
Journal:  J Mol Neurosci       Date:  2013-09-05       Impact factor: 3.444

6.  Review of epidemiologic studies of aluminium and neurological disorders.

Authors:  G F Craun
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

7.  The economic costs of Alzheimer's disease.

Authors:  J W Hay; R L Ernst
Journal:  Am J Public Health       Date:  1987-09       Impact factor: 9.308

Review 8.  Recent advances in the understanding of dementia.

Authors:  P Tyrrell; M Rossor
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

9.  Androgen receptor gene and sex-specific Alzheimer's disease.

Authors:  Raffaele Ferrari; Saad Dawoodi; Merrill Raju; Avinash Thumma; Linda S Hynan; Shirin Hejazi Maasumi; Joan S Reisch; Sid O'Bryant; Marjorie Jenkins; Robert Barber; Parastoo Momeni
Journal:  Neurobiol Aging       Date:  2013-03-29       Impact factor: 4.673

10.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.